M&A and regulatory activity seen as key drivers in Indian market in 2011
This article was originally published in Scrip
Executive Summary
2011 promises to be an action-packed year in India, with more pharma multinationals (MNCs) expected to buy into the country and enhanced regulatory activity likely to be another prominent feature, according to some industry pundits.